Mariner JC, Jones BA, Rich KM, Thevasagayam S, Anderson J, Jeggo M, Cai Y, Peters AR, Roeder PL (2016) The opportunity to eradicate peste des petits ruminants. J Immunol 196:3499–3506. https://doi.org/10.4049/jimmunol.1502625
Article CAS PubMed Google Scholar
Plotkin S (2014) History of vaccination. Proc Natl Acad Sci 111:12283–12287. https://doi.org/10.1073/pnas.1400472111
Article CAS PubMed PubMed Central Google Scholar
Schrobback P, Dennis G, Li Y, Mayberry D, Shaw A, Knight-Jones T, Marsh TL, Pendell DL, Torgerson PR, Gilbert W, Huntington B (2023) Approximating the global economic (market) value of farmed animals. Glob Food Sec 39:100722. https://doi.org/10.1016/j.gfs.2023.100722
Article PubMed PubMed Central Google Scholar
Morens DM, Taubenberger JK, Fauci AS (2023) Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe 31:146–157. https://doi.org/10.1016/j.chom.2022.11.016
Article CAS PubMed PubMed Central Google Scholar
Entrican G, Francis MJ (2022) Applications of platform technologies in veterinary vaccinology and the benefits for one health. Vaccine 40:2833–2840. https://doi.org/10.1016/j.vaccine.2022.03.059
Article CAS PubMed Google Scholar
Van Der Loo JC, Wright JF (2016) Progress and challenges in viral vector manufacturing. Hum Mol Genet 25:R42–R52. https://doi.org/10.1093/hmg/ddv451
Article CAS PubMed Google Scholar
Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A (2023) The evolution of SARS-CoV-2. Nat Rev Microbiol 21:361–379. https://doi.org/10.1038/s41579-023-00878-2
Article CAS PubMed Google Scholar
Cui S, Liu Y, Zhao J, Peng X, Lu G, Shi W, Pan Y, Zhang D, Yang P, Wang Q (2022) An updated review on SARS-CoV-2 infection in animals. Viruses 14:1527. https://doi.org/10.3390/v14071527
Article CAS PubMed PubMed Central Google Scholar
Sandoval C, Guerrero D, Muñoz J, Godoy K, Souza-Mello V, Farlas J (2023) Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review. Expert Rev Vaccines 22:35–53. https://doi.org/10.1080/14760584.2023.2156861
Article CAS PubMed Google Scholar
McCann N, O’Connor D, Lambe T, Pollard AJ (2022) Viral vector vaccines. Curr Opin Immunol 77:102210. https://doi.org/10.1016/j.coi.2022.102210
Article CAS PubMed PubMed Central Google Scholar
Jackson DA, Symons RH, Berg P (1972) Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli. Proc Natl Acad Sci 69:2904–2909. https://doi.org/10.1073/pnas.69.10.2904
Article CAS PubMed PubMed Central Google Scholar
Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci 79:7415–7419. https://doi.org/10.1073/pnas.79.23.7415
Article CAS PubMed PubMed Central Google Scholar
Kohn DB, Mitsuya H, Ballow M, Selegue JE, Barankiewicz J, Cohen A, Gelfand E, Anderson WF, Blaese RM (1989) Establishment and characterization of adenosine deaminase-deficient human T cell lines. J Immunol 142:3971–3977. https://doi.org/10.4049/jimmunol.142.11.3971
Article CAS PubMed Google Scholar
Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH (2007) Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Vaccine 25:4213–4222. https://doi.org/10.1016/j.vaccine.2007.02.084
Article CAS PubMed Google Scholar
Barnard AR, Groppe M, MacLaren RE (2015) Gene therapy for choroideremia using an adeno-associated viral (AAV) vector. Cold Spring Harb Perspect Med 5:a017293. https://doi.org/10.1101/cshperspect.a017293
Article CAS PubMed Central Google Scholar
Tang N, Zhang Y, Pedrera M, Chang P, Baigent S, Moffat K, Shen Z, Nair V, Yao Y (2018) A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system. Vaccine 36:716–722. https://doi.org/10.1016/j.vaccine.2017.12.025
Article CAS PubMed PubMed Central Google Scholar
Marzi A, Feldmann F, O’Donnell KL, Hanley PW, Messaoudi I, Feldmann H (2023) Preexisting immunity does not prevent efficacy of VSV-based filovirus vaccines in nonhuman primates. J Infect Dis 6:66. https://doi.org/10.1093/infdis/jiad208
Oliveira GP, Rodrigues RAL, Lima MT, Drumond BP, Abrahao JS (2017) Poxvirus host range genes and virus–host spectrum: a critical review. Viruses 9:331. https://doi.org/10.3390/v9110331
Article CAS PubMed PubMed Central Google Scholar
Vrba SM, Kirk NM, Brisse ME, Liang Y, Ly H (2020) Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats. Vaccines 8:680. https://doi.org/10.3390/vaccines8040680
Article CAS PubMed PubMed Central Google Scholar
Orlova OV, Glazkova DV, Bogoslovskaya EV, Shipulin GA, Yudin SM (2022) Development of modified vaccinia virus Ankara-based vaccines: advantages and applications. Vaccines 10:1516. https://doi.org/10.3390/vaccines10091516
Article CAS PubMed PubMed Central Google Scholar
Xie L, Li Y (2022) Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development. Vaccine. https://doi.org/10.1016/j.vaccine.2022.10.047
Article PubMed PubMed Central Google Scholar
Satterfield BA, Mire CE, Geisbert TW (2023) Overview of experimental vaccines and antiviral therapeutics for Henipavirus infection. In: Nipah virus: methods and protocols. Springer, New York, pp 1–22. https://doi.org/10.1007/978-1-0716-3283-3_1
Syyam A, Nawaz A, Ijaz A, Sajjad U, Fazil A, Irfan S, Muzaffar A, Shahid M, Idrees M, Malik K, Afzal S (2022) Adenovirus vector system: Construction, history and therapeutic applications. Biotechniques 73:297–305. https://doi.org/10.2144/btn-2022-0051
Article CAS PubMed Google Scholar
Zhang H, Wang H, An Y, Chen Z (2023) Construction and application of adenoviral vectors. Mol Therapy Nucleic Acids 34:66. https://doi.org/10.1016/j.omtn.2023.09.004
Danthinne X, Imperiale MJ (2000) Production of first generation adenovirus vectors: a review. Gene Ther 7:1707–1714. https://doi.org/10.1038/sj.gt.3301301
Article CAS PubMed Google Scholar
Sayedahmed EE, Elkashif A, Alhashimi M, Sambhara S, Mittal SK (2020) Adenoviral vector-based vaccine platforms for developing the next generation of influenza vaccines. Vaccines 8:574. https://doi.org/10.3390/vaccines8040574
Article CAS PubMed PubMed Central Google Scholar
Gonzalez-Aparicio M, Bunuales M, de Landazuri IO, Prieto J, Hernandez-Alcoceba R (2023) Application of a split-Cre system for high-capacity adenoviral vector amplification. Biotechnol J 18:2200227. https://doi.org/10.1002/biot.202200227
Elahi SM, Nazemi-Moghaddam N, Guilbault C, Simoneau M, Gilbert R (2023) Complement
留言 (0)